Ir para o conteúdo

Max Wolff

@trpwolff.bsky.social did:plc:m2b7df5p4dq5c3sxb4ppmc54

Psychologist, psychotherapist and clinician-researcher with research focus on psychedelic therapy Humboldt-Universität zu Berlin

No Bluesky desde

Seguidores
1.546
Seguindo
278
Posts
270
Dias nos rankings
0

Resumo

Max Wolff (@trpwolff.bsky.social) é um usuário do Bluesky desde 14 outubro 2023. Tem 1.546 seguidores, segue 278 contas e publicou 270 posts.

Aparições nos rankings

Os melhores dias em que posts desta conta entraram na lista diária do Debya.

Esta conta ainda não apareceu em um ranking diário.

Posts curtidos recentemente

Curtidas públicas da rede Bluesky.

  • Manoj Doss not exist@manojdoss.bsky.social

    We got a new review/model on why we think psychedelics might be particularly useful in the treatment of anxiety-related disorders. link.springer.com/article/10.1... Good work @htmcgovern.bsky.social on carrying this through the finish line.

    Ver post
  • Hugh McGovern PhD@htmcgovern.bsky.social

    Being a psychedelic enthusiast accounts for a huge amount of how psychedelics increase quality of life. In other words, the drug is not the territory. Will publish on this issue soon.

    Ver post
  • Rich Haridy@richharidy.bsky.social

    New data drop from Definium's phase 3 LSD for anxiety trial. This one is most interesting for its dose response data. Only the second dose response phase 3 read out after Compass. Here are the two readouts. Compass comparing 10mg of psilocybin against 25mg and Definium comparing 50mcg LSD to 100.

    Ver post
  • Hugh McGovern PhD@htmcgovern.bsky.social

    New single just dropped. link.springer.com/article/10.1...

    Ver post
  • Manoj Doss not exist@manojdoss.bsky.social

    New paper on the phenomenology of heightened familiarity under psychedelics! www.tandfonline.com/doi/full/10....

    Ver post

Entre para ver mais

Contas que bloqueia

No Bluesky, bloqueios são registros públicos.